Neurodegenerative disease Archives

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

Delve into the field of miRNA with seven companies with miRNA-focused candidates in the pipeline in 2024, from oncology to neurodegeneration.

November 26, 2024 - 9 minutesmins - By Jules Adam

In Depth 21 Nov 2024

Huntington’s disease: a therapeutic field on a bumpy ride

For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope.

November 21, 2024 - 9 minutesmins - By Roohi Mariam Peter

20S proteasome activation: Berlin biotech Booster Therapeutics secures $15 million for innovative therapies to tackle neurodegenerative diseases

News and Trends 15 Oct 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.

October 15, 2024 - 6 minutesmins - By Jules Adam

In Depth 26 Sep 2024

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation.

September 26, 2024 - 14 minutesmins - By Jules Adam

In Depth 19 Sep 2024

Mitochondrial disease treatments: is a breakthrough on the horizon?

Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases.

September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 1 Aug 2024

European regulators reject Alzheimer’s drug Leqembi: is it downhill from here?

European regulators have now refused to market the Alzheimer’s drug Leqembi after it was approved by the FDA last year.

August 1, 2024 - 6 minutesmins - By Roohi Mariam Peter

More News! 17 Jul 2024

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

Discover yet another exciting deal in biotech with Asceneuron raising $100 million to advance its Alzheimer’s candidate, ASN51.

July 17, 2024 - 10 minutesmins - By Jules Adam

In Depth 4 Jul 2024

Parkinson’s disease: biotech’s pursuit for more therapies

Rigorous research aims to boost therapeutic options for people with Parkinson’s disease. What do biotechs have in store?

July 4, 2024 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 May 2024

Stem cell therapy’s avant-garde: Eight companies leading the way

Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.

May 30, 2024 - 11 minutesmins - By Jules Adam

alchemyrefiner alchemymagic 1 37c41ba7 555f 4f93 ad44 39b31d752775 0

Podcast 15 Mar 2024

Reformulating psychedelics for neurodegenerative diseases

Discover how Terran Biosciences is at the forefront of revolutionizing neurological care through innovative psychedelics treatments.

March 15, 2024

In Depth 4 Mar 2024

ALS: how close are we to a cure?

Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.

March 4, 2024 - 9 minutesmins - By Roohi Mariam Peter

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases.

January 23, 2024 - 9 minutesmins - By External Contributor

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Neurodegenerative disease

Seven miRNA-focused companies pioneering new therapies in 2024

Huntington’s disease: a therapeutic field on a bumpy ride

Booster launches to treat neurodegenerative diseases with proteasome activation

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Mitochondrial disease treatments: is a breakthrough on the horizon?

European regulators reject Alzheimer’s drug Leqembi: is it downhill from here?

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

Parkinson’s disease: biotech’s pursuit for more therapies

Stem cell therapy’s avant-garde: Eight companies leading the way

Reformulating psychedelics for neurodegenerative diseases

ALS: how close are we to a cure?

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!